As an event partner of the stellar professional gathering, it is our pleasure to quote from the conference organizers the names of the well-known brands in the Pharmacovigilance space who have confirmed their attendance so far:
Heads of Pharmacovigilance, Regulatory Affairs and Clinical Operations from:
- Bristol-Myers Squibb
- Eli Lilly Japan
- Johnson & Johnson
- Ministry of Health, Singapore
If you've always wanted to learn the secrets of:
- Achieving compliance in various country regulations in Asia while meeting global safety requirements via 9 regulatory updates from WHO, China, India, Taiwan, South Korea, Malaysia and Brunei
- Developing and implementing risk management and minimisation plans for improved drug safety
- Preparing for audit and inspection via practical steps to get it right
- Establishing an early signal detection system for improved drug safety
- Best practices in AE reporting for post-marketing surveillance studies
What's more? There is a special 15% discount in the conference registration fee for the subscribers of Oviya MedSafe's newsletter, of whom you are one!
To avail the benefit, quote "CM15 " when you register at email@example.com and save up to SGD4,096!
For further assistance, please contact the organizers directly at:
Tel: +65 6722 9388
We look forward to meeting you next fortnight at Singapore!
With best regards,
Dr J Vijay Venkatraman.
Founder & CEO,
Oviya MedSafe Pvt. Ltd.
Pharmacovigilance Consulting & Services
A Proud Event Partner of 3rd Pharmacovigilance Asia 2012, Singapore